Dehydrocostus Lactone Ameliorates LPS‐Induced Acute Lung Injury by Inhibiting PFKFB3‐Mediated Glycolysis
Journal of Cellular Biochemistry · 2024-10 · 125 (10)
DOI: 10.1002/jcb.30639 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular Biochemistry, online erschienen am 15.08.2024. Verfasst von Yue Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin, China. Hauptthemen laut MEDLINE: Phosphofructokinase-2, Acute Lung Injury, Lipopolysaccharides, Glycolysis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: This study was funded by the National Natural Science Foundation of China (Grant: 82304822) and Tianjin University of Technology Graduate Research Innovation P….
Abstract (Originalsprache)
Acute lung injury (ALI) is a destructive respiratory disease characterized by alveolar structural destruction and excessive inflammation responses. Aerobic glycolysis of macrophages plays a crucial role in the pathophysiology of ALI. Previous studies have shown that the expression of the key rate‐limiting enzyme 6‐phosphofructo‐2‐kinase/fructose‐2,6‐bisphosphatase 3 (PFKFB3) in inflammatory cells is significantly increased, which promotes an increase in the rate of glycolysis in inflammatory cells. However, little is known about the biological functions of PFKFB3 in macrophage inflammation and ALI. In this study, we identified that PFKFB3 is markedly increased in lipopolysaccharide (LPS)‐induced ALI mice and macrophages. Knockdown of pfkfb3 attenuated LPS‐induced glycolytic flux, decreased the release of pro‐inflammatory cytokines, and inactivated NF‐κB signaling pathway in macrophages. Subsequently, we found that dehydrocostus lactone (DL), a natural sesquiterpene lactone, significantly decreased both the mRNA and protein levels of PFKFB3. Furthermore, it reduced the release of inflammatory cytokines and inactivated NF‐κB pathways in vitro. Accordingly, DL alleviated LPS‐induced pulmonary edema and reduced the infiltration of inflammatory cells in mouse lung tissue. In summary, our study reveals the vital role of PFKFB3 in LPS‐induced inflammation and discovers a novel molecular mechanism underlying DL's protective effects on ALI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin, China.
- Department of Molecular Pharmacology, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China.
- Department of Biochemistry and Molecular Biology, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
ORCID-Profile: Dongrong Zhu
Förderung
- This study was funded by the National Natural Science Foundation of China (Grant: 82304822) and Tianjin University of Technology Graduate Research Innovation P…
Zitieren
APA
Li, Y., Wang, X., Zhao, L., Pan, B., Xu, X., & Zhu, D. (2024). Dehydrocostus Lactone Ameliorates LPS‐Induced Acute Lung Injury by Inhibiting PFKFB3‐Mediated Glycolysis. Journal of Cellular Biochemistry, 125(10). https://doi.org/10.1002/jcb.30639
Vancouver
Li Y, Wang X, Zhao L, Pan B, Xu X, Zhu D. Dehydrocostus Lactone Ameliorates LPS‐Induced Acute Lung Injury by Inhibiting PFKFB3‐Mediated Glycolysis. Journal of Cellular Biochemistry. 2024;125(10). doi:10.1002/jcb.30639
BibTeX
@article{Li2024,
author = {Li, Yue and Wang, Xinrui and Zhao, Lirong and Pan, Boyu and Xu, Xiao and Zhu, Dongrong},
title = {Dehydrocostus Lactone Ameliorates LPS‐Induced Acute Lung Injury by Inhibiting PFKFB3‐Mediated Glycolysis},
journal = {Journal of Cellular Biochemistry},
year = {2024},
volume = {125},
number = {10},
doi = {10.1002/jcb.30639}
}
EUVIMED